Cassia Tora (Chakramarda): The Underrated Skin and Liver Herb in Ayurvedic Texts

Among the less widely marketed herbs of Ayurvedic materia medica, Cassia tora Linn. occupies a distinctive position. In classical and pharmacopoeial usage it is known by names such as Chakramarda, Prapunnada, Edagaja, and Dadrughna; the last name itself points to its valued role in dadru, the ring-shaped itchy skin disorder commonly correlated with tinea-like presentations. The dried seed is listed in the Ayurvedic Pharmacopoeia of India as Prapunnada, with “Ring Worm Plant” and “Fetid Cassia” as English names, and its main actions are centred on skin, itching, worms, constipation, and Kapha-Vata disorders.

The herb’s modern phytochemical profile fits this traditional focus. Cassia tora contains anthraquinones, naphthopyrone glycosides, flavonoids, fixed oil, and related phenolic constituents. These include chrysophanol, emodin, rhein, physcion, aloe-emodin, cassiaside, rubrofusarin derivatives, torachrysone, and toralactone-related compounds. This makes Chakramarda especially relevant in a practical Ayurvedic discussion of stubborn itching, recurrent fungal-type skin complaints, thickened or scaly skin conditions, short-term constipation support, and carefully supervised liver-support contexts.

Classical Identity and Ayurvedic Profile

The Ayurvedic Pharmacopoeia of India describes Prapunnada as the dried seed of Cassia tora Linn., an annual herb occurring as a weed throughout India’s plains and ascending to the Central Himalayas. The official seed monograph gives its rasa as katu, guna as laghu and ruksha, virya as ushna, and vipaka as katu. Its listed karmas include rechana, Kapha-Vata-shamaka, krimighna, lekhana, kushthaghna, vishaghna, varnaprasadakara, and tvachya.

This profile explains why Chakramarda is not merely a “skin herb” in a cosmetic sense. Katu rasa, laghu-ruksha guna, and ushna virya make it drying, scraping, warming, and Kapha-reducing. In classical Ayurvedic terms, this is useful where itching, circular lesions, dampness, heaviness, oozing tendency, thickening, or Kapha-Vata involvement dominates. The API therapeutic indications include kushtha, vrana vikara, dadru, vibandha, gulma, krimi, pama, kandu, shvasa, and kasa.

Phytochemical Profile

The seed monograph of Prapunnada lists anthraquinones and fixed oil as constituents. Broader phytochemical reviews of Cassia tora describe different constituents in seeds, leaves, roots, and flowers, with seeds especially rich in anthraquinone and naphthopyrone derivatives. The important point for Ayurvedic use is that the plant contains compounds relevant to itching, fungal-type skin complaints, laxative action, antioxidant pathways, and inflammatory skin models, while still requiring conservative dosing.

• Anthraquinones: Seeds and leaves contain compounds such as chrysophanol, emodin, physcion, rhein, aloe-emodin, and related derivatives. Chrysophanic acid-9-anthrone has been identified in the literature as an important antifungal principle of Cassia tora, and anthraquinone-rich fractions have been associated with antifungal and antibacterial activity in laboratory contexts.
• Emodin: Emodin is a naturally occurring anthraquinone found in several medicinal plants, including Cassia tora. Its pharmacological profile includes anti-inflammatory, antimicrobial, antioxidant, hepatoprotective, and antiproliferative activity in experimental models. In an Ayurvedic herb article, this supports Chakramarda’s relevance to inflammatory and chronic skin discussions without turning it into a cancer or metabolic-disease remedy.
• Naphthopyrone glycosides: Cassiaside, rubrofusarin-6-O-β-D-gentiobioside, and related naphthopyrone glycosides have been isolated from the seeds. Some seed glycosides have been evaluated for antihepatotoxic and antioxidant-type activity, making the liver-support discussion plausible only within supervised, non-emergency use.
• Flavonoids: Leaves contain flavonoid derivatives including quercetin- and luteolin-related compounds. These are relevant to the discussion of scaly and inflammatory skin conditions, particularly where topical formulations are considered by a practitioner.
• Fixed oil and seed gum: The seed contains fixed oil and polysaccharide-rich material. These constituents contribute more to the pharmacognostic and formulation identity of the seed than to a simple single-compound explanation of its action.

Ayurvedic Applications

Chakramarda is best understood as a focused herb for Kapha-Vata skin disorders with itching, ring-like lesions, roughness, scaling, or parasitic association, with a secondary role as a short-term rechana herb. It should not be presented as a broad daily supplement. Its potency lies in targeted use, correct preparation, correct diagnosis, and short, practitioner-guided courses.

Fungal-Type Skin Complaints and Dadru

Dadru is the most characteristic application of Chakramarda. The pharmacopoeial synonym Dadrughna, the English name “Ring Worm Plant,” and the API indication of dadru all point to this primary use. Classical lepa-style applications use Chakramarda seed or related combinations externally in skin disorders, while modern phytochemistry identifies anthraquinones and chrysophanic acid-9-anthrone as relevant constituents for antifungal-type activity.

In practice, powdered seed may be prepared as a paste with clean water or a classical sour medium when prescribed, then applied locally for a limited period under guidance. The skin should not be aggressively abraded, covered tightly, or treated repeatedly if burning, blistering, spreading redness, pus, fever, or worsening irritation appears. A circular rash is not always simple ringworm, so persistent or recurrent lesions require medical diagnosis.

Itching, Pama, and Kapha-Type Skin Irritation

The API lists kandu and pama among Prapunnada’s therapeutic uses, and its karmas include kushthaghna, krimighna, lekhana, and tvachya. This makes Chakramarda suitable in traditional formulations where itching is associated with Kapha accumulation, dampness, rough eruptions, or suspected parasitic involvement. It is usually more appropriate for moist, itchy, Kapha-dominant presentations than for very dry, cracked, highly inflamed Pitta-Vata skin.

External preparations may be chosen as paste, medicated oil, or compound lepa depending on the condition. Internal use, when needed, is usually kept within the classical powder dose and combined with diet, hygiene, bowel regulation, and other herbs according to the practitioner’s assessment.

Psoriasis-Like Scaling and Kitibha-Type Presentations

Chakramarda appears in traditional discussions of chronic skin disease, including thickened or scaly presentations such as kitibha. Experimental work with Cassia tora leaf extracts and isolated flavonoids has also been directed at psoriasis-like skin models. This supports its inclusion in practitioner-designed external formulations for scaly, itchy, chronic lesions, but it does not justify unsupervised internal treatment for psoriasis.

For psoriasis-like disease, Chakramarda is usually only one part of a wider plan. Ayurveda considers digestion, bowel habit, diet, incompatible foods, stress, chronic inflammation, and dosha involvement. Conventional assessment is important when plaques are widespread, painful, infected, bleeding, associated with joint pain, or not clearly diagnosed.

Liver-Support Context

Cassia tora leaf and seed preparations have shown hepatoprotective activity in experimental liver-injury models, including carbon tetrachloride and galactosamine-related models. The relevant constituents include anthraquinones, naphthopyrone glycosides, and antioxidant phenolics. This gives Chakramarda a reasonable place in a cautious pharmacognosy discussion of liver-support herbs, but not as a self-treatment for jaundice, hepatitis, fatty liver disease, or abnormal liver tests.

Any visible jaundice, dark urine, pale stools, persistent nausea, right upper abdominal pain, fever, swelling, unexplained weight loss, or abnormal liver enzymes requires evaluation by a physician. If Chakramarda is used in a liver-support context, it should be part of a qualified practitioner’s plan with attention to dose, duration, bowel effects, and medication interactions.

Short-Term Constipation Support

The API lists rechana as a karma and vibandha as a therapeutic use of Prapunnada. This supports its traditional role in constipation, especially where Kapha-Vata obstruction, heaviness, sluggishness, and skin complaints coexist. The seed should not be treated as a casual daily laxative; anthraquinone-containing laxatives are generally intended for short-term use.

For adults, the API dose for Prapunnada seed powder is 1–3 g. The lowest effective dose is preferred, and prolonged use should be avoided because stimulant-laxative patterns can aggravate dependency, cramping, diarrhoea, dehydration, and electrolyte imbalance. Constipation with severe abdominal pain, vomiting, blood in stool, unexplained weight loss, or sudden bowel change needs medical assessment.

Preparation and Dosage Guide

The safest public guidance is to stay close to the official pharmacopoeial dose and to distinguish between external and internal use. Classical formulas vary by disease, vehicle, and processing method; therefore, concentrated extracts, capsules, and proprietary products should not be dosed by simply converting the crude-powder dose.

Safety and Contraindications

Chakramarda is a potent medicinal herb, not a routine wellness powder. Because the seed contains anthraquinone-type constituents and has rechana action, internal use should be conservative, short-term, and avoided in unsuitable patients. External use can also irritate sensitive skin if applied too strongly or too frequently.

• Pregnancy and breastfeeding: Avoid internal use unless a qualified physician specifically advises otherwise.
• Children: Avoid unsupervised internal use in children; anthraquinone laxative sensitivity is higher in younger age groups.
• Inflammatory bowel disease or bowel obstruction: Avoid in active Crohn’s disease, ulcerative colitis, intestinal obstruction, severe dehydration, unexplained abdominal pain, or suspected appendicitis.
• Diarrhoea or dehydration: Do not use internally when loose stools, dehydration, electrolyte imbalance, or severe weakness is present.
• Kidney disease, heart disease, or diuretic use: Use only with medical supervision because laxative-induced fluid and electrolyte shifts may be risky.
• Liver disease: Do not self-treat jaundice, hepatitis, fatty liver disease, cirrhosis, or abnormal liver enzymes with Chakramarda.
• Skin diagnosis: Do not assume every circular, itchy, or scaly lesion is fungal. Persistent lesions, bleeding lesions, changing moles, non-healing ulcers, pus, fever, or spreading redness require medical evaluation.
• Duration: Avoid long-term oral use; stimulant-laxative patterns are best reserved for short courses under guidance.

Nothing in this article diagnoses, treats, or cures a medical condition. Chakramarda should be used under the guidance of a qualified Ayurvedic practitioner or healthcare provider, especially if pregnant, breastfeeding, treating a child, managing chronic skin disease, liver disease, bowel disease, kidney disease, or taking medication.

References

1. Ayurvedic Pharmacopoeia of India
2. Iafaforallergy (iafaforallergy.com)
3. Nopr (nopr.niscpr.res.in)
4. Prosea (prosea.prota4u.org)
5. Prosea (prosea.prota4u.org)
6. Derpharmachemica (derpharmachemica.com)
7. Abp (abp.ptbioch.edu.pl)
8. Potential hepatoprotective activity of ononitol monohydrate isolated from Cassia tora L. on carbon tetrachloride induced hepatotoxicity in wistar rats (2009), PubMed
9. Cassia tora Linn Cream Inhibits Ultraviolet-B-Induced Psoriasis in Rats (2012), PubMed Central
10. Scielo (scielo.br)
11. Scielo (scielo.br)
12. Ema (ema.europa.eu)